GlassScriptPhysician profile
Jason C Levitre
NPI 1326017179
$5,920.84
in general payments reported to CMS, 2019-2025
23 companies · $392 in 2025
The $392 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,164 · 2020: $470 · 2021: $600 · 2022: $1,574 · 2023: $279 · 2024: $442 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,846.77 | 2019-2020 | |
| Stryker Corporation | $1,068.99 | 2022-2025 | 7 X 23mm Citrelock Implant |
| Smith+Nephew, INC. | $947.76 | 2020-2025 | Grafix Pl, Stravix, Oasis |
| Cook Medical LLC | $305.67 | 2019-2020 | |
| Ossio INC | $230.65 | 2021-2022 | |
| Horizon Therapeutics Plc | $217.13 | 2019-2023 | Krystexxa |
| Treace Medical Concepts, INC. | $201.38 | 2021 | |
| Paratek Pharmaceuticals, INC. | $198.98 | 2024-2025 | Nuzyra |
| Abbott Laboratories | $158.30 | 2019-2020 | |
| Organogenesis INC. | $158.22 | 2022-2023 | Puraply |
| Limflow INC. | $134.62 | 2023 | Limflow System |
| Cgg Medical INC | $132.25 | 2022 | |
| Kerecis Limited | $80.39 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Ibsa Pharma INC. | $37.96 | 2020-2025 | Flector, Licart, Tirosint |
| Zimmer Biomet Holdings, INC. | $33.88 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Oxygen Therapy INC. | $32.12 | 2021-2024 | Topical Oxygen Chamber For Extremities |
| Kowa Pharmaceuticals America, INC. | $30.61 | 2022 | |
| Cashflow Solutions, LLC | $22.98 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Abbvie INC. | $19.33 | 2021 | |
| Kci USA, INC. | $18.75 | 2023 | Prevena, Activ.A.C. |
| Misonix INC | $17.31 | 2021 | |
| Medtronic, INC. | $14.89 | 2023 | Intellis Adaptivestim |
| Djo, LLC | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Levitre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.